antipyrine has been researched along with Brain Swelling in 34 studies
Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Edaravone is widely used for treating ischemic stroke, but it is not still confirmed in intracerebral hemorrhage (ICH) as an ideal medication targeting the brain parenchyma." | 7.83 | Stereotactic Administration of Edaravone Ameliorates Collagenase-Induced Intracerebral Hemorrhage in Rat. ( Gao, M; Ge, GZ; Ji, XC; Sun, YL; Wang, QQ; Xu, RX; Yang, Y; Zhang, GZ; Zhang, HT; Zhang, Y, 2016) |
| "To investigate the protective effect of edaravone and danshensu conjugate (IM-009) on focal cerebral ischemia-reperfusion injury in rats and its underlying mechanisms." | 7.81 | [Protective effect of novel edaravone and danshensu conjugate on focal cerebral ischemia-reperfusion injury in rats and its underlying mechanism]. ( Chen, H; Hou, S; Zhang, S, 2015) |
| "In present study, we evaluated acute neuroprotective effects of combined therapy with pharmacologically induced hypothermia and edaravone in a rat model of intracerebral hemorrhage (ICH)." | 7.81 | Early Combined Therapy with Pharmacologically Induced Hypothermia and Edaravone Exerts Neuroprotective Effects in a Rat Model of Intracerebral Hemorrhage. ( Liu, C; Sun, Z; Zhu, Y, 2015) |
| " In the first, the dose-dependent effects of edaravone on ICH-induced brain injury were examined by measuring brain edema and neurologic deficits." | 7.74 | Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage. ( Itano, T; Keep, RF; Kuroda, Y; Miyamoto, O; Nagao, S; Nakamura, T; Tamiya, T; Xi, G; Yamashita, S; Zhang, X, 2008) |
| " autoradiogram of 14C-iodoantipyrine, on the course of brain edema correspond to each other or not." | 7.71 | Dissociation of brain edema induced by cold injury in rat model: MR imaging and perfusion studies with 14C-iodo-antipyrine. ( Abe, Y; Abo, M; Itabashi, Y; Miura, H; Prado, GL, 2001) |
| "We investigated whether or not a combination of the selective thrombin inhibitor, argatroban, and the free radical scavenger, edaravone (MCI-186), ameliorates postischemic hypoperfusion and decreases mortality after 15 min of forebrain ischemia in the gerbil." | 7.71 | Combined argatroban and edaravone caused additive neuroprotection against 15 min of forebrain ischemia in gerbils. ( Jin, YJ; Mima, T; Park, KC; Raicu, V; Shimizu, K, 2002) |
| "Montelukast was injected intraperitoneally either as multiple doses (once a day for 3 days and 30 min before MCAO) or as a single dose (at 30 min before, 30 min after, or 1 h after MCAO), respectively, and pranlukast and edaravone were used as controls." | 5.33 | Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice. ( Chen, Z; Chu, LS; Mei, RH; Wei, EQ; Xu, HM; Yu, GL; Zhang, Q; Zhang, SH; Zhang, WP; Zhao, MH, 2005) |
| "Edaravone is widely used for treating ischemic stroke, but it is not still confirmed in intracerebral hemorrhage (ICH) as an ideal medication targeting the brain parenchyma." | 3.83 | Stereotactic Administration of Edaravone Ameliorates Collagenase-Induced Intracerebral Hemorrhage in Rat. ( Gao, M; Ge, GZ; Ji, XC; Sun, YL; Wang, QQ; Xu, RX; Yang, Y; Zhang, GZ; Zhang, HT; Zhang, Y, 2016) |
| " Previous studies have demonstrated that the free radical scavenger edaravone may prevent neuronal injury and brain edema after ICH." | 3.81 | The radical scavenger edaravone improves neurologic function and perihematomal glucose metabolism after acute intracerebral hemorrhage. ( Cui, D; Liang, S; Shang, H; Yang, D; Zhang, W; Zhao, W, 2015) |
| "To investigate the protective effect of edaravone and danshensu conjugate (IM-009) on focal cerebral ischemia-reperfusion injury in rats and its underlying mechanisms." | 3.81 | [Protective effect of novel edaravone and danshensu conjugate on focal cerebral ischemia-reperfusion injury in rats and its underlying mechanism]. ( Chen, H; Hou, S; Zhang, S, 2015) |
| "In present study, we evaluated acute neuroprotective effects of combined therapy with pharmacologically induced hypothermia and edaravone in a rat model of intracerebral hemorrhage (ICH)." | 3.81 | Early Combined Therapy with Pharmacologically Induced Hypothermia and Edaravone Exerts Neuroprotective Effects in a Rat Model of Intracerebral Hemorrhage. ( Liu, C; Sun, Z; Zhu, Y, 2015) |
| "Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a free radical scavenger, reduces brain edema in patients with acute ischemic stroke." | 3.74 | Edaravone inhibits the expression of vascular endothelial growth factor in human astrocytes exposed to hypoxia. ( Imaizumi, T; Ishikawa, A; Matsumiya, T; Metoki, N; Satoh, K; Taima, K; Toki, T; Yamashita, K; Yoshida, H, 2007) |
| " In the first, the dose-dependent effects of edaravone on ICH-induced brain injury were examined by measuring brain edema and neurologic deficits." | 3.74 | Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage. ( Itano, T; Keep, RF; Kuroda, Y; Miyamoto, O; Nagao, S; Nakamura, T; Tamiya, T; Xi, G; Yamashita, S; Zhang, X, 2008) |
| " autoradiogram of 14C-iodoantipyrine, on the course of brain edema correspond to each other or not." | 3.71 | Dissociation of brain edema induced by cold injury in rat model: MR imaging and perfusion studies with 14C-iodo-antipyrine. ( Abe, Y; Abo, M; Itabashi, Y; Miura, H; Prado, GL, 2001) |
| "We investigated whether or not a combination of the selective thrombin inhibitor, argatroban, and the free radical scavenger, edaravone (MCI-186), ameliorates postischemic hypoperfusion and decreases mortality after 15 min of forebrain ischemia in the gerbil." | 3.71 | Combined argatroban and edaravone caused additive neuroprotection against 15 min of forebrain ischemia in gerbils. ( Jin, YJ; Mima, T; Park, KC; Raicu, V; Shimizu, K, 2002) |
| "Edaravone was associated with delayed evolution of infarcts and edema in patients with severe carotid-territorial stroke and decreased mortality during the acute stage." | 2.71 | Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion. ( Arihiro, S; Fujii, K; Ibayashi, S; Iida, M; Kamouchi, M; Nakane, H; Okada, Y; Toyoda, K, 2004) |
| "Edaravone was approved in Japan for the treatment of acute brain infarction within 24 h after onset in April, 2001." | 2.41 | [Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent]. ( Tanaka, M, 2002) |
| "Edaravone was treated twice via tail vein; after MCA occlusion and after reperfusion." | 1.43 | A free radical scavenger edaravone suppresses systemic inflammatory responses in a rat transient focal ischemia model. ( Arai, K; Fujiwara, N; Lee, BJ; Lo, EH; Mandeville, ET; Pham, LD; Som, AT, 2016) |
| "Montelukast was injected intraperitoneally either as multiple doses (once a day for 3 days and 30 min before MCAO) or as a single dose (at 30 min before, 30 min after, or 1 h after MCAO), respectively, and pranlukast and edaravone were used as controls." | 1.33 | Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice. ( Chen, Z; Chu, LS; Mei, RH; Wei, EQ; Xu, HM; Yu, GL; Zhang, Q; Zhang, SH; Zhang, WP; Zhao, MH, 2005) |
| "Edaravone-treated animals showed significantly improved neurological outcome." | 1.33 | Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats. ( Amemiya, S; Inaba, T; Kamiya, T; Katayama, Y; Kato, K; Nito, C; Shimazaki, K; Ueda, M, 2005) |
| "Cerebral ischemia was mechanically induced by 2-hour occlusion of the left middle cerebral artery (MCA) using an intraluminal filament followed by 24-hour reperfusion." | 1.33 | Lack of antiapoptotic effects of antiplatelet drug, aspirin and clopidogrel, and antioxidant, MCI-186, against focal ischemic brain damage in rats. ( Hong, KW; Lee, JH; Lee, WS; Park, SY, 2005) |
| "Cerebral infarct volume and cerebral edema were measured by high-contrast silver infarct staining (SIS)." | 1.31 | Early effects of acid-base management during hypothermia on cerebral infarct volume, edema, and cerebral blood flow in acute focal cerebral ischemia in rats. ( Frietsch, T; Georgiadis, D; Kollmar, R; Kuschinsky, W; Schäbitz, WR; Schwab, S; Waschke, KF, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (23.53) | 18.7374 |
| 1990's | 1 (2.94) | 18.2507 |
| 2000's | 17 (50.00) | 29.6817 |
| 2010's | 8 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, C | 1 |
| Bryant, A | 1 |
| Brown, PD | 1 |
| Fang, W | 1 |
| Zhang, R | 1 |
| Sha, L | 1 |
| Lv, P | 1 |
| Shang, E | 1 |
| Han, D | 1 |
| Wei, J | 1 |
| Geng, X | 1 |
| Yang, Q | 1 |
| Li, Y | 1 |
| Chen, Z | 2 |
| Zhang, J | 2 |
| Chen, Q | 1 |
| Guo, J | 1 |
| Zhu, G | 1 |
| Feng, H | 1 |
| Shang, H | 1 |
| Cui, D | 1 |
| Yang, D | 1 |
| Liang, S | 1 |
| Zhang, W | 1 |
| Zhao, W | 1 |
| Zhang, S | 1 |
| Hou, S | 1 |
| Chen, H | 1 |
| Zhu, Y | 1 |
| Liu, C | 1 |
| Sun, Z | 1 |
| Zhang, Y | 1 |
| Yang, Y | 1 |
| Zhang, GZ | 1 |
| Gao, M | 1 |
| Ge, GZ | 1 |
| Wang, QQ | 1 |
| Ji, XC | 1 |
| Sun, YL | 1 |
| Zhang, HT | 1 |
| Xu, RX | 1 |
| Fujiwara, N | 1 |
| Som, AT | 1 |
| Pham, LD | 1 |
| Lee, BJ | 1 |
| Mandeville, ET | 1 |
| Lo, EH | 1 |
| Arai, K | 1 |
| Zhou, F | 1 |
| Chen, G | 1 |
| Kikuchi, K | 1 |
| Tancharoen, S | 1 |
| Matsuda, F | 1 |
| Biswas, KK | 1 |
| Ito, T | 1 |
| Morimoto, Y | 1 |
| Oyama, Y | 1 |
| Takenouchi, K | 1 |
| Miura, N | 1 |
| Arimura, N | 1 |
| Nawa, Y | 1 |
| Meng, X | 1 |
| Shrestha, B | 1 |
| Arimura, S | 1 |
| Iwata, M | 1 |
| Mera, K | 1 |
| Sameshima, H | 1 |
| Ohno, Y | 1 |
| Maenosono, R | 1 |
| Tajima, Y | 1 |
| Uchikado, H | 1 |
| Kuramoto, T | 1 |
| Nakayama, K | 1 |
| Shigemori, M | 1 |
| Yoshida, Y | 1 |
| Hashiguchi, T | 1 |
| Maruyama, I | 1 |
| Kawahara, K | 1 |
| Kollmar, R | 1 |
| Frietsch, T | 1 |
| Georgiadis, D | 1 |
| Schäbitz, WR | 1 |
| Waschke, KF | 1 |
| Kuschinsky, W | 1 |
| Schwab, S | 1 |
| Nakamura, H | 1 |
| Uzura, M | 1 |
| Uchida, K | 1 |
| Nakayama, H | 1 |
| Furuya, Y | 1 |
| Hayashi, T | 1 |
| Sekino, H | 1 |
| Ominato, M | 1 |
| Owada, S | 1 |
| Toyoda, K | 1 |
| Fujii, K | 1 |
| Kamouchi, M | 1 |
| Nakane, H | 1 |
| Arihiro, S | 1 |
| Okada, Y | 1 |
| Ibayashi, S | 1 |
| Iida, M | 1 |
| Yu, GL | 1 |
| Wei, EQ | 1 |
| Zhang, SH | 1 |
| Xu, HM | 1 |
| Chu, LS | 1 |
| Zhang, WP | 1 |
| Zhang, Q | 1 |
| Mei, RH | 1 |
| Zhao, MH | 1 |
| Shinohara, Y | 1 |
| Amemiya, S | 1 |
| Kamiya, T | 1 |
| Nito, C | 1 |
| Inaba, T | 1 |
| Kato, K | 1 |
| Ueda, M | 1 |
| Shimazaki, K | 1 |
| Katayama, Y | 2 |
| Lee, JH | 1 |
| Park, SY | 1 |
| Lee, WS | 1 |
| Hong, KW | 1 |
| Suda, S | 1 |
| Igarashi, H | 1 |
| Arai, Y | 1 |
| Andou, J | 1 |
| Chishiki, T | 1 |
| Niyaz, M | 1 |
| Numakawa, T | 1 |
| Matsuki, Y | 1 |
| Kumamaru, E | 1 |
| Adachi, N | 1 |
| Kitazawa, H | 1 |
| Kunugi, H | 1 |
| Kudo, M | 1 |
| Ishikawa, A | 1 |
| Yoshida, H | 1 |
| Metoki, N | 1 |
| Toki, T | 1 |
| Imaizumi, T | 1 |
| Matsumiya, T | 1 |
| Yamashita, K | 1 |
| Taima, K | 1 |
| Satoh, K | 1 |
| Nakamura, T | 1 |
| Kuroda, Y | 1 |
| Yamashita, S | 1 |
| Zhang, X | 1 |
| Miyamoto, O | 1 |
| Tamiya, T | 1 |
| Nagao, S | 1 |
| Xi, G | 1 |
| Keep, RF | 1 |
| Itano, T | 1 |
| Le Poncin-Lafitte, M | 1 |
| Grosdemouge, C | 1 |
| Roy-Billon, C | 1 |
| Duterte, D | 1 |
| Rapin, JR | 1 |
| Watanabe, T | 3 |
| Egawa, M | 1 |
| Itabashi, Y | 1 |
| Prado, GL | 1 |
| Abo, M | 1 |
| Miura, H | 1 |
| Abe, Y | 1 |
| Kilic, E | 1 |
| Bähr, M | 1 |
| Hermann, DM | 1 |
| Tanaka, M | 1 |
| Jin, YJ | 1 |
| Mima, T | 1 |
| Raicu, V | 1 |
| Park, KC | 1 |
| Shimizu, K | 1 |
| Nishi, H | 2 |
| Sakurai, H | 1 |
| Yuki, S | 1 |
| Ishibashi, A | 1 |
| Milhorat, TH | 1 |
| Johnson, WD | 1 |
| Dow-Edwards, DL | 1 |
| Oishi, R | 1 |
| Itoh, Y | 1 |
| Nishibori, M | 1 |
| Saeki, K | 1 |
| Shigeno, T | 1 |
| Teasdale, GM | 1 |
| McCulloch, J | 1 |
| Graham, DI | 1 |
| O'Brien, MD | 1 |
| Jordan, MM | 1 |
| Waltz, AG | 2 |
| Yamaguchi, T | 1 |
| Regli, F | 1 |
| Potchen, EJ | 1 |
| Adatepe, MH | 1 |
| Studer, R | 1 |
| Penkoske, M | 1 |
| Penkoske, P | 1 |
| Perez, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multicenter Randomized Open-Label Comparison Study on the Efficacy and Safety of Argatroban Monotherapy With Argatroban-Edaravone Combination Therapy[NCT00153946] | Phase 4 | 814 participants (Actual) | Interventional | 2004-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for antipyrine and Brain Swelling
| Article | Year |
|---|---|
Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery.
Topics: Adrenal Cortex Hormones; Adult; Antipyrine; Bevacizumab; Brain; Brain Edema; Drug Therapy, Combinati | 2018 |
[Clinical guidelines for stroke].
Topics: Anticoagulants; Antipyrine; Arginine; Aspirin; Brain Edema; Edaravone; Fibrinolytic Agents; Free Rad | 2004 |
[Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent].
Topics: Animals; Antipyrine; Brain Edema; Clinical Trials as Topic; Depression, Chemical; Edaravone; Free Ra | 2002 |
1 trial available for antipyrine and Brain Swelling
| Article | Year |
|---|---|
Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion.
Topics: Aged; Antipyrine; Atrial Fibrillation; Brain Edema; Carotid Artery Thrombosis; Carotid Artery, Inter | 2004 |
30 other studies available for antipyrine and Brain Swelling
| Article | Year |
|---|---|
Platelet activating factor induces transient blood-brain barrier opening to facilitate edaravone penetration into the brain.
Topics: Animals; Antipyrine; ATP Binding Cassette Transporter, Subfamily B; Blood-Brain Barrier; Blotting, W | 2014 |
Neuroprotective effects of edaravone after intraventricular hemorrhage in rats.
Topics: Animals; Antipyrine; Brain Edema; Cerebral Hemorrhage; Cognition Disorders; Edaravone; Free Radical | 2014 |
The radical scavenger edaravone improves neurologic function and perihematomal glucose metabolism after acute intracerebral hemorrhage.
Topics: Animals; Antipyrine; Behavior, Animal; Body Water; Brain Edema; Cell Death; Edaravone; Fluorodeoxygl | 2015 |
[Protective effect of novel edaravone and danshensu conjugate on focal cerebral ischemia-reperfusion injury
in rats and its underlying mechanism].
Topics: Animals; Antipyrine; Brain Edema; Brain Ischemia; Cerebral Infarction; Edaravone; Lactates; Malondia | 2015 |
Early Combined Therapy with Pharmacologically Induced Hypothermia and Edaravone Exerts Neuroprotective Effects in a Rat Model of Intracerebral Hemorrhage.
Topics: Animals; Antipyrine; Apoptosis Regulatory Proteins; Blood-Brain Barrier; Blotting, Western; Brain Ed | 2015 |
Stereotactic Administration of Edaravone Ameliorates Collagenase-Induced Intracerebral Hemorrhage in Rat.
Topics: Animals; Antipyrine; Apoptosis; Blood-Brain Barrier; Brain Edema; Cerebral Hemorrhage; Collagenases; | 2016 |
A free radical scavenger edaravone suppresses systemic inflammatory responses in a rat transient focal ischemia model.
Topics: Animals; Antipyrine; Brain Edema; Cerebral Infarction; Cytokines; Edaravone; Free Radical Scavengers | 2016 |
Edaravone reduces brain oedema and attenuates cell death after intracerebral haemorrhage in mice.
Topics: Animals; Antipyrine; Brain; Brain Edema; Cell Death; Cerebral Hemorrhage; Collagenases; Disease Mode | 2009 |
Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4.
Topics: Animals; Antipyrine; Aquaporin 4; Brain Edema; Brain Ischemia; Disease Models, Animal; Edaravone; Fr | 2009 |
Early effects of acid-base management during hypothermia on cerebral infarct volume, edema, and cerebral blood flow in acute focal cerebral ischemia in rats.
Topics: Acid-Base Equilibrium; Animals; Antipyrine; Autoradiography; Brain Edema; Brain Ischemia; Cerebral I | 2002 |
Effects of edaravone on experimental brain injury in view of free radical reaction.
Topics: Animals; Antipyrine; Body Water; Brain; Brain Edema; Brain Injuries; Edaravone; Electron Spin Resona | 2003 |
Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
Topics: Acetates; Animals; Antipyrine; Blood-Brain Barrier; Brain; Brain Edema; Brain Ischemia; Chromones; C | 2005 |
Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats.
Topics: Animals; Antipyrine; Apoptosis; bcl-2-Associated X Protein; Brain Edema; Brain Ischemia; Cerebral Co | 2005 |
Lack of antiapoptotic effects of antiplatelet drug, aspirin and clopidogrel, and antioxidant, MCI-186, against focal ischemic brain damage in rats.
Topics: Animals; Antioxidants; Antipyrine; Aspirin; bcl-2-Associated X Protein; Blotting, Western; Brain Ede | 2005 |
Effect of edaravone, a free radical scavenger, on ischemic cerebral edema assessed by magnetic resonance imaging.
Topics: Aged; Aged, 80 and over; Antipyrine; Brain Edema; Brain Ischemia; Edaravone; Female; Free Radical Sc | 2007 |
MCI-186 prevents brain tissue from neuronal damage in cerebral infarction through the activation of intracellular signaling.
Topics: Animals; Animals, Newborn; Antipyrine; Brain Edema; Butadienes; Cell Death; Cells, Cultured; Cerebra | 2007 |
Edaravone inhibits the expression of vascular endothelial growth factor in human astrocytes exposed to hypoxia.
Topics: Antipyrine; Astrocytes; Blood-Brain Barrier; Brain Edema; Cell Nucleus; Cells, Cultured; Cerebral Ar | 2007 |
Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage.
Topics: Acute Disease; Animals; Antipyrine; Basal Ganglia; Brain Edema; Cerebral Cortex; Cerebral Hemorrhage | 2008 |
[Cerebral blood flow, metabolism and learning after a cerebral infarction in the rat (author's transl)].
Topics: Animals; Antipyrine; Avoidance Learning; Brain; Brain Edema; Cerebral Infarction; Cerebrovascular Ci | 1981 |
Effects of an antistroke agent MCl-186 on cerebral arachidonate cascade.
Topics: Animals; Antipyrine; Arachidonic Acid; Brain; Brain Edema; Cerebrovascular Disorders; Chromones; Eda | 1994 |
Dissociation of brain edema induced by cold injury in rat model: MR imaging and perfusion studies with 14C-iodo-antipyrine.
Topics: Animals; Antipyrine; Autoradiography; Brain Edema; Carbon Radioisotopes; Cold Temperature; Female; M | 2001 |
Effects of recombinant tissue plasminogen activator after intraluminal thread occlusion in mice: role of hemodynamic alterations.
Topics: Animals; Antipyrine; Autoradiography; Brain Edema; Brain Ischemia; Cerebrovascular Circulation; Colo | 2001 |
Combined argatroban and edaravone caused additive neuroprotection against 15 min of forebrain ischemia in gerbils.
Topics: Animals; Anticoagulants; Antipyrine; Arginine; Body Water; Brain Edema; Brain Ischemia; Cerebral Inf | 2002 |
Effect of MCI-186 on brain edema in rats.
Topics: Animals; Antipyrine; Brain Edema; Dexamethasone; Edaravone; Free Radicals; Lipid Peroxides; Lipoxyge | 1989 |
Relationship between oedema, blood pressure, and blood flow following local brain injury.
Topics: Animals; Antipyrine; Blood Pressure; Brain Edema; Brain Injuries; Cerebrovascular Circulation; Male; | 1989 |
Effect of MCI-186 on ischemia-induced changes in monoamine metabolism in rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipyrine; Biogenic Monoamines; Brain; Brain Edema; Brain | 1989 |
Recirculation model following MCA occlusion in rats. Cerebral blood flow, cerebrovascular permeability, and brain edema.
Topics: Aminoisobutyric Acids; Antipyrine; Arterial Occlusive Diseases; Autoradiography; Brain Edema; Brain | 1985 |
Ischemic cerebral edema and the blood-brain barrier. Distributions of pertechnetate, albumin, sodium, and antipyrine in brains of cats after occlusion of the middle cerebral artery.
Topics: Albumins; Animals; Antipyrine; Blood-Brain Barrier; Brain; Brain Edema; Cats; Cerebrovascular Disord | 1974 |
Effects of hyperventilation with and without carbon dioxide on experimental cerebral ischaemia and infarction. Studies of regional cerebral blood flow and histopathology after occlusion of a middle cerebral artery in cats.
Topics: Animals; Antipyrine; Autoradiography; Brain; Brain Edema; Carbon Dioxide; Carbon Isotopes; Cats; Cer | 1972 |
Radioisotopic assessment of cerebral edema.
Topics: Animals; Antipyrine; Brain Edema; Erythrocytes; Female; Iodine Radioisotopes; Iron Isotopes; Methods | 1971 |